Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Early research (Phase 1)UnknownNCT05928962
What this trial is testing

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Who this might be right for
Malignant Melanomas
Fujian Cancer Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00448227
What this trial is testing

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

Who this might be right for
Herpes Simplex
Novartis 18
Not applicableStudy completedNCT01737710
What this trial is testing

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study

Who this might be right for
Dermatitis, Atopic
National Institute of Allergy and Infectious Diseases (NIAID) 368
Very early researchEnded earlyNCT05507996
What this trial is testing

Recombinant Adeno-associated Virus Administration for Patients With Menkes Syndrome

Who this might be right for
Menkes Syndrome
Kunming Hope of Health Hospital 1
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Post-approval studies (Phase 4)Ended earlyNCT00122655
What this trial is testing

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Who this might be right for
HIV InfectionsHIV Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 100
Not applicableUnknownNCT04822090
What this trial is testing

Parvovirus B19 Infection in Hereditary Hemolytic Anemias Patients

Who this might be right for
Parvovirus B19 Infection
Sohag University 244
Testing effectiveness (Phase 2)Active Not RecruitingNCT04445844
What this trial is testing

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma+2 more
Mridula George, MD 25
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Not applicableStudy completedNCT00763295
What this trial is testing

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?

Who this might be right for
Latent TuberculosisHIV Infections
Northwell Health 53
Large-scale testing (Phase 3)Study completedNCT00698568
What this trial is testing

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Who this might be right for
Prophylaxis for Herpes Simplex
GlaxoSmithKline 7,460
Early research (Phase 1)Ended earlyNCT00005993
What this trial is testing

Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer

Who this might be right for
Breast CancerLymphoma
Masonic Cancer Center, University of Minnesota
Not applicableUnknownNCT04567576
What this trial is testing

Predictive Factors for COVID-19 in Rheumatology

Who this might be right for
Rheumatic DiseasesCovid19
Fundación Santa Fe de Bogota 150
Testing effectiveness (Phase 2)Study completedNCT02665260
What this trial is testing

Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum

Who this might be right for
Molluscum Contagiosum
Montefiore Medical Center 94
Not applicableStudy completedNCT04335279
What this trial is testing

Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program

Who this might be right for
SclerodermaScleroderma, SystemicSystemic Sclerosis
Lady Davis Institute 172
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)UnknownNCT00002817
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Not applicableStudy completedNCT00015691
What this trial is testing

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Who this might be right for
HIV InfectionsLipodystrophyHyperinsulinemia
National Institute of Allergy and Infectious Diseases (NIAID) 105
Testing effectiveness (Phase 2)WithdrawnNCT05561491
What this trial is testing

ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Who this might be right for
Melanoma
Targovax Oy
Next Page